Literature DB >> 25952989

DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS.

Susanne E Ahmari1, Darin D Dougherty2.   

Abstract

Obsessive-compulsive disorder (OCD) is a chronic, severe mental illness with up to 2-3% prevalence worldwide. In fact, OCD has been classified as one of the world's 10 leading causes of illness-related disability according to the World Health Organization, largely because of the chronic nature of disabling symptoms.([1]) Despite the severity and high prevalence of this chronic and disabling disorder, there is still relatively limited understanding of its pathophysiology. However, this is now rapidly changing due to development of powerful technologies that can be used to dissect the neural circuits underlying pathologic behaviors. In this article, we describe recent technical advances that have allowed neuroscientists to start identifying the circuits underlying complex repetitive behaviors using animal model systems. In addition, we review current surgical and stimulation-based treatments for OCD that target circuit dysfunction. Finally, we discuss how findings from animal models may be applied in the clinical arena to help inform and refine targeted brain stimulation-based treatment approaches.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  anxiety; basal ganglia; cortico-striato-thalamo-cortical circuits; deep brain stimulation (DBS); obsessive-compulsive disorder (OCD); optogenetics; orbitofrontal cortex (OFC); prefrontal cortex; transcranial magnetic stimulation (TMS); ventral striatum

Mesh:

Year:  2015        PMID: 25952989      PMCID: PMC4515165          DOI: 10.1002/da.22367

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  141 in total

1.  An optogenetic toolbox designed for primates.

Authors:  Ilka Diester; Matthew T Kaufman; Murtaza Mogri; Ramin Pashaie; Werapong Goo; Ofer Yizhar; Charu Ramakrishnan; Karl Deisseroth; Krishna V Shenoy
Journal:  Nat Neurosci       Date:  2011-01-30       Impact factor: 24.884

Review 2.  A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.

Authors:  Dan J Stein; Nastassja Koen; Naomi Fineberg; Leonardo F Fontenelle; Hisato Matsunaga; David Osser; H Blair Simpson
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

3.  Compulsions, Parkinson's disease, and stimulation.

Authors:  Luc Mallet; Valérie Mesnage; Jean-Luc Houeto; Antoine Pelissolo; Jérôme Yelnik; Cécile Behar; Marcella Gargiulo; Marie-Laure Welter; Anne-Marie Bonnet; Bernard Pillon; Philippe Cornu; Didier Dormont; Bernard Pidoux; Jean-François Allilaire; Yves Agid
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

4.  Reversible online control of habitual behavior by optogenetic perturbation of medial prefrontal cortex.

Authors:  Kyle S Smith; Arti Virkud; Karl Deisseroth; Ann M Graybiel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

5.  Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Jesen A Fagerness; Jill Platko; Jordan W Smoller; Jeremiah M Scharf; Cornelia Illmann; Eric Jenike; Nadia Chabane; Marion Leboyer; Richard Delorme; Michael A Jenike; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

Review 6.  The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.

Authors:  L C Barr; W K Goodman; L H Price; C J McDougle; D S Charney
Journal:  J Clin Psychiatry       Date:  1992-04       Impact factor: 4.384

Review 7.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Joshua P Aronson; Husam A Katnani; Emad N Eskandar
Journal:  Neurosurg Clin N Am       Date:  2013-11-01       Impact factor: 2.509

8.  Meta-analysis of brain volume changes in obsessive-compulsive disorder.

Authors:  Jean-Yves Rotge; Dominique Guehl; Bixente Dilharreguy; Jean Tignol; Bernard Bioulac; Michele Allard; Pierre Burbaud; Bruno Aouizerate
Journal:  Biol Psychiatry       Date:  2008-08-21       Impact factor: 13.382

9.  Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder.

Authors:  Stella J de Wit; Pino Alonso; Lizanne Schweren; David Mataix-Cols; Christine Lochner; José M Menchón; Dan J Stein; Jean-Paul Fouche; Carles Soriano-Mas; Joao R Sato; Marcelo Q Hoexter; Damiaan Denys; Takashi Nakamae; Seiji Nishida; Jun Soo Kwon; Joon Hwan Jang; Geraldo F Busatto; Narcís Cardoner; Danielle C Cath; Kenji Fukui; Wi Hoon Jung; Sung Nyun Kim; Euripides C Miguel; Jin Narumoto; Mary L Phillips; Jesus Pujol; Peter L Remijnse; Yuki Sakai; Na Young Shin; Kei Yamada; Dick J Veltman; Odile A van den Heuvel
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

10.  Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice.

Authors:  Sergey V Shmelkov; Adília Hormigo; Deqiang Jing; Catia C Proenca; Kevin G Bath; Till Milde; Evgeny Shmelkov; Jared S Kushner; Muhamed Baljevic; Iva Dincheva; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; George D Yancopoulos; Ipe Ninan; Francis S Lee; Shahin Rafii
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

View more
  35 in total

Review 1.  Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Authors:  Rachel J Sizemore; Sonja Seeger-Armbruster; Stephanie M Hughes; Louise C Parr-Brownlie
Journal:  J Neurophysiol       Date:  2016-02-17       Impact factor: 2.714

2.  Animal models of OCD-relevant processes: an RDoC perspective.

Authors:  Christopher Pittenger; Helen Pushkarskaya; Patricia Gruner
Journal:  J Obsessive Compuls Relat Disord       Date:  2019-04-03       Impact factor: 1.677

3.  Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression.

Authors:  Claudia Delgado-Acevedo; Sebastián F Estay; Anna K Radke; Ayesha Sengupta; Angélica P Escobar; Francisca Henríquez-Belmar; Cristopher A Reyes; Valentina Haro-Acuña; Elías Utreras; Ramón Sotomayor-Zárate; Andrew Cho; Jens R Wendland; Ashok B Kulkarni; Andrew Holmes; Dennis L Murphy; Andrés E Chávez; Pablo R Moya
Journal:  Neuropsychopharmacology       Date:  2018-12-26       Impact factor: 7.853

Review 4.  Obsessive-compulsive disorder: Insights from animal models.

Authors:  Henry Szechtman; Susanne E Ahmari; Richard J Beninger; David Eilam; Brian H Harvey; Henriette Edemann-Callesen; Christine Winter
Journal:  Neurosci Biobehav Rev       Date:  2016-05-07       Impact factor: 8.989

5.  Prepulse Inhibition Deficits in Obsessive-Compulsive Disorder are More Pronounced in Females.

Authors:  Susanne E Ahmari; Victoria B Risbrough; Mark A Geyer; H Blair Simpson
Journal:  Neuropsychopharmacology       Date:  2016-12       Impact factor: 7.853

6.  The bed nucleus: a future hot spot in obsessive compulsive disorder research?

Authors:  S Kohl; J C Baldermann; J Kuhn
Journal:  Mol Psychiatry       Date:  2016-04-12       Impact factor: 15.992

Review 7.  The role of the orbitofrontal cortex in alcohol use, abuse, and dependence.

Authors:  David E Moorman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-02-09       Impact factor: 5.067

8.  Invasive and Non-invasive Neurostimulation for OCD.

Authors:  Isidoor O Bergfeld; Eva Dijkstra; Ilse Graat; Pelle de Koning; Bastijn J G van den Boom; Tara Arbab; Nienke Vulink; Damiaan Denys; Ingo Willuhn; Roel J T Mocking
Journal:  Curr Top Behav Neurosci       Date:  2021

9.  Histamine modulation of the basal ganglia circuitry in the development of pathological grooming.

Authors:  Maximiliano Rapanelli; Luciana Frick; Haruhiko Bito; Christopher Pittenger
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

10.  Contemporary strategies for dissecting the neuronal basis of neurodevelopmental disorders.

Authors:  Dong-Oh Seo; Laura E Motard; Michael R Bruchas
Journal:  Neurobiol Learn Mem       Date:  2018-03-14       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.